Corrigendum to 'Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-b1 pathway' [Eur. J. Med. Chem. 157 (2018) 229-247]
Eur J Med Chem. 2019 Feb 1:163:403.
doi: 10.1016/j.ejmech.2018.11.071.
Epub 2018 Dec 7.
1 College of Pharmacy, The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, People's Republic of China.
2 Department of Respiratory and Critical Care Medicine, Pingjin Hospital, Logistics University of Chinese People's Armed Police Forces, Tianjin, 300162, People's Republic of China.
3 College of Pharmacy, The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, People's Republic of China. Electronic address: guang.yang@nankai.edu.cn.